Showing results (81-90 of 176) with videos related to
Sort By:
Pageof 18
Cancer Research|April 29, 2010
Transcriptional repression of SKP2 is impaired in MYCN-amplified neuroblastomaDaniel Muth, Seda Ghazaryan, Isabella Eckerle, et al.Translational Oncology|January 28, 2014
Testing of SNS-032 in a Panel of Human Neuroblastoma Cell Lines with Acquired Resistance to a Broad Range of DrugsNadine Löschmann, Martin Michaelis, Florian Rothweiler, et al.Cancers|November 25, 2020
Identification of VRK1 as a New Neuroblastoma Tumor Progression Marker Regulating Cell ProliferationAna Colmenero-Repiso, María A Gómez-Muñoz, Ismael Rodríguez-Prieto, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2007
High Skp2 expression characterizes high-risk neuroblastomas independent of MYCN statusFrank Westermann, Kai-Oliver Henrich, Jun S Wei, et al.Gut|September 12, 2021
Histone H3K27 demethylase KDM6A is an epigenetic gatekeeper of mTORC1 signalling in cancerSteffie Revia, Agnieszka Seretny, Lena Wendler, et al.Nature Communications|March 24, 2019
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcomaYe Chen, Liang Xu, Anand Mayakonda, et al.Gut|September 2, 2017
Identification of distinct mutational patterns and new driver genes in oesophageal squamous cell carcinomas and adenocarcinomasDe-Chen Lin, Huy Q Dinh, Jian-Jun Xie, et al.Leukemia|August 9, 2025
Towards methylation-based redefinition of TAL1 positive T-cell acute lymphoblastic leukaemia (T-ALL)Charlotte Smith, Guillaume Charbonnier, Mathieu Simonin, et al.Nature Cell Biology|February 23, 2010
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasisLi Ma, Jennifer Young, Harsha Prabhala, et al.Science Signaling|December 24, 2015
Signaling pathway models as biomarkers: Patient-specific simulations of JNK activity predict the survival of neuroblastoma patientsDirk Fey, Melinda Halasz, Daniel Dreidax, et al.Pageof 18